Kathy Baker: Founding My Faulty Gene & Surviving Hereditary Cancer
Walking the Genetic Line
EPISODE SUMMARY Kathy Baker grew up in a family that, as she puts it, "looked like a poster for a BRCA mutation" — a sister diagnosed with breast cancer at 31, a mother with three primary cancers, a grandfather lost to aggressive prostate cancer, a great-grandmother lost to pancreatic cancer. And still, when genetic testing became available, Kathy said no. Not out of denial exactly, but out of a fierce instinct to protect her own life from being lived under a shadow. She was diagnosed with breast cancer herself in 2000, treated without ever seeing an oncologist first, and then spent nine...
info_outline
Elana Silber: The Chain You Inherit
Walking the Genetic Line
EPISODE SUMMARY Sharsheret is the Hebrew word for chain. Not a ribbon, not a fight, not a cure — a chain. Twenty-five years in, that name turns out to be the most precise available description of the work: over 40,000 people who have shared their experience, peer matches made not by mutation status but by the specific thing you are afraid of, social workers and genetic counselors who answer the phone, pre- and post-surgery kits arriving at the house wrapped and unbilled, and more than a million dollars a year moving quietly toward the non-medical costs that make a diagnosis expensive in ways...
info_outline
Holly Taylor: Hard-Earned Wisdom
Walking the Genetic Line
Episode Summary A visible tumor changed two lives at once. When Holly Taylor’s sister was diagnosed at 45 with simultaneous stage 3 ovarian and breast cancer — tumors large enough to see with the naked eye, discovered only after years of avoiding care without health insurance — genetic testing entered Holly’s life as an extension of her sister’s crisis rather than a decision of her own. An initial variant of unknown significance sat unresolved for two years before being reclassified as a pathogenic BRCA1 mutation, arriving in the middle of a four-and-a-half-year caregiving arc that...
info_outline
Marleah Dean Kruzel: You Make the Best Decision You Can — A Researcher’s Honest Take on BRCA and Uncertainty
Walking the Genetic Line
Guest: Marleah Dean Kruzel, PhD Theme: Uncertainty as a Lifetime Companion, Not a Problem to Solve Episode Summary Marleah Dean Kruzel was 8 years old when her mother found a lump. What followed were years of surgeries, chemotherapy, radiation, and a childhood lived largely in hospitals — experiences that eventually became the foundation of a research career dedicated to understanding what previvors actually go through, and what the systems meant to support them consistently fail to provide. She tested positive for BRCA2 in 2013, after letting the test kit sit in the back of her safe for...
info_outline
Natalie Samson Hart: How Integrative Genetic Counseling Changes What Comes Next
Walking the Genetic Line
Guest: Natalie Samson Hart, MS, CGC, INHC Theme: Genetic Counseling as a Gateway to Whole-Person Care Episode Summary Natalie Samson Hart didn’t come to oncology genetic counseling through a tidy career trajectory. She came through loss, confusion, and proximity to illness — a brother whose neurodivergence led her toward the intersection of science and human connection, a father diagnosed with stage 4 cancer while she was still in graduate school and rotating through cancer wards. That collision of the personal and professional is what eventually pushed her out of traditional...
info_outline
Krista Brown: ATM Mutation, Delayed Diagnosis, and What Self-Advocacy Actually Costs
Walking the Genetic Line
Guest: Krista (Oncology Nurse Navigator) Theme: Self-Advocacy, ATM Mutation, Cancer After Previvorhood EPISODE SUMMARY When Krista's mother was 48, she became the first known cancer diagnosis in their family. She tested negative for BRCA mutations and felt relief — relief that she wouldn't pass anything on to her children. Twelve years later, just before entering hospice, she was offered expanded genetic testing and found out she carried a pathogenic ATM variant. She shared those results with her children. A few months after her death, Krista — 38 years old, a nurse, carrying...
info_outline
Ali Hall: Prophylactic Mastectomy, Queer Identity, and Claiming Your Body on Your Own Terms
Walking the Genetic Line
Guest: Ali Hall Theme: Queer Identity, Bodily Autonomy, and the BRCA Diagnosis Nobody Saw Coming Episode Summary When Ali Hall stole a 23andMe kit from a family white elephant exchange, she wasn't looking for anything life-changing. Five years later, an email arrived while she was picking her kid up from school: her results had been updated. She had a BRCA mutation. What followed wasn't panic — and that itself is the story. Ali's response was shaped by something older than the diagnosis: a lifelong pattern of minimizing her own experience when people around her were...
info_outline
Jennifer Mercer: Lynch Syndrome Awareness and the Weight of a Father's Legacy
Walking the Genetic Line
Episode Summary Jennifer never knew her biological father growing up — and when she finally let him back into her life at 25, what he brought with him was a medical history that would change everything. Phone call after phone call, a new cancer. Eight-plus organ cancers. Over a hundred skin cancers. Years before anyone thought to offer him a genetic test. When Lynch Syndrome MSH2 was finally identified, Jennifer wasn't ready — she was a single mother, financially stretched, emotionally guarded, and carrying decades of unresolved grief toward a man who had never shown up for her. She put...
info_outline
Solo Episode: Living with Hereditary Cancer and Risk in a Loud World
Walking the Genetic Line
Host: Sara Champie, LCSW Theme: Navigating medical vulnerability, global instability, and nervous system overwhelm during hereditary cancer risk and treatment. Episode summary What happens when your body is healing, your life is medically uncertain, and the world around you feels like it’s unraveling? In this solo episode, therapist Sara Champie explores a reality many people navigating hereditary cancer risk quietly experience: the nervous system strain of managing personal medical vulnerability while absorbing the constant noise of global crisis. When surgery, treatment, or high-stakes...
info_outline
Katie McMurray: The Emotional Impact of Grief, Sisterhood, and Preventative Surgery
Walking the Genetic Line
Guest: Katie McMurray Theme: BRCA1, sisterhood, developmental trauma, and choosing preventative surgery in young adulthood Episode summary When Katie was 17, she lost her mother to breast cancer. Years later, genetic testing confirmed what she had long suspected: she carries a BRCA1 mutation. In this episode, Katie and Sara Champie explore what happens when grief resurfaces through genetic testing — how identity shifts, how fear and agency intertwine, and how the loss of a parent shapes medical decision-making. At 25, during the height of COVID, Katie chose preventative mastectomy surgery....
info_outlineEPISODE SUMMARY
Sharsheret is the Hebrew word for chain. Not a ribbon, not a fight, not a cure — a chain. Twenty-five years in, that name turns out to be the most precise available description of the work: over 40,000 people who have shared their experience, peer matches made not by mutation status but by the specific thing you are afraid of, social workers and genetic counselors who answer the phone, pre- and post-surgery kits arriving at the house wrapped and unbilled, and more than a million dollars a year moving quietly toward the non-medical costs that make a diagnosis expensive in ways no one warns you about. One story in this conversation holds the whole thesis: a family that did not talk about cancer, a mother who died of ovarian cancer at 63, a daughter who had tested negative and considered the matter closed — and then a facilitated call where nine siblings, cameras off, began comparing notes and discovered a family history none of them had individually been able to name. Months later, one of them was recovering from surgery.
What this conversation opens up is the part of hereditary risk that lives in the family system rather than the chart. Disclosure is not an information transfer; it is a negotiation with estrangement, obligation, guilt, and the relative who says I don't want to know. New reproductive technology does not relieve responsibility so much as redistribute it — including onto the partner who carries the mutation and watches someone else's body absorb the procedures. And for Ashkenazi Jewish families, where one in 40 carries a BRCA mutation compared with roughly one in 400 in the general population, all of this lands inside a community identity already built around endurance, at a moment when that community is under additional strain. Picture the High Holidays: a liturgy that asks aloud who shall live and who shall die, recited in a room where you are the only one who knows there is a surgery on your calendar.
WE COVER
-
The chain as infrastructure, not metaphor: How one organization built a parallel system for everything the medical appointment structurally cannot hold — one-on-one support, community education, and direct financial assistance for the non-medical costs that quietly determine whether people can follow through on care.
-
Peer matching by fear, not by gene: Why being connected to someone who shares your mutation is not the same as being connected to someone who shares your specific concern — fertility, timing, surgical recovery, going back to work — and why the second one is what actually reduces isolation.
-
The family call that broke a generational silence: Nine siblings, cameras off, a mother lost to ovarian cancer at 63, and a "negative" result that had prematurely closed the conversation — an example of intergenerational emotional inheritance surfacing only when someone outside the family system holds the container.
-
Disclosure as a relational act: The push-pull of telling family members you may have handed them something, the relative who refuses the information, the sibling whose number you don't have — and what it takes to draft that text when the relationship itself is the complication.
-
Why the oophorectomy frightens people more than the mastectomy: Surgical menopause arriving overnight, the absence of reliable ovarian cancer screening, the fallopian-tube-first approach for younger patients, and the osteoporosis and cardiovascular trade-offs that make this a genuine decision rather than an obvious one.
-
Testing after diagnosis, not only before it: The persistent belief among survivors that genetic information no longer matters once cancer has already arrived — and why treatment protocols, panel testing for CHEK2, PALB2, ATM, and Lynch syndrome, and family implications say otherwise.
-
Embryo screening and the arrival of new guilt: Preimplantation genetic testing as a real option and a real weight — what happens when every embryo returns positive, how partners who carry the mutation experience watching, and the specific ache of people who would have chosen this if it had existed.
-
Cultural identity as clinical context: Education and the protection of life as community values, materials adapted for communities that will not print the word breast, the High Holidays as a time-based emotional reactivation, and the post-October 7th experience of carrying a diagnosis you cannot burden your family with.
-
The waiting room: The stretch between the test and the result treated as its own event rather than dead time — because the mind will write a full-length novel in that gap if left alone with it.
HIGHLIGHTS & TAKEAWAYS
-
The urge to help other people is often the first thing to come back online after a diagnosis, and it frequently arrives before you have received anything yourself — which is worth noticing, because it can look like recovery when it is actually the responsibility reflex resuming its post.
-
Fear does not scale to the size of the incision; it scales to what the procedure threatens, which is why a laparoscopic surgery can be more terrifying than a mastectomy and why dismissing that as irrational misses the entire point.
-
A negative result is not always the end of the story — medically, because family history still counts, and emotionally, because relief does not automatically reach the parts of you that have been braced since childhood.
-
Silence in a family is rarely about the information itself; it is about what that family has learned to do with feeling, which is why a single facilitated conversation can surface a history nine people were each privately holding.
-
More options do not automatically produce more freedom — when the choices are irreversible and the outcomes are probabilistic, expanded agency can arrive as expanded exposure to blame.
-
The waiting is not a preamble to the experience; it is part of the experience, and the fact that it has no medical name does not mean your nervous system is not running the whole time.
CONTENT NOTE
This conversation includes discussion of cancer diagnosis and the death of a parent from ovarian cancer, mastectomy and ovary-removal surgery, surgical menopause and hormonal changes, weight and body changes, fertility treatment and decisions about embryos, family estrangement and difficult disclosure conversations, and the financial cost of cancer care. It also includes discussion of antisemitism and the strain many Jewish families experienced after October 7th, 2023. If any of these are close to the surface for you right now, you may want to choose your moment for this one.
RESOURCES MENTIONED
- Sharsheret — sharsheret.org | Toll-free: 866-474-2774 | Instagram: @sharsheretofficial National organization providing free one-on-one support, peer matching, genetic counseling, community education, and financial assistance for people and families facing hereditary breast and ovarian cancer risk or diagnosis. Rooted in the Jewish community and open to everyone.
- Sharsheret's Peer Support Network — Matching based on your specific situation and concerns, not just mutation status; can be done anonymously.
- Sharsheret's pre- and post-surgery kits — Free, mailed to your home, developed and updated based on what people going through surgery said they wished they'd had.
- The Waiting Room (Sharsheret) — Support during the interval between testing and results.
- The Mammogrant (Sharsheret) — A giving program tied to mammogram appointments.
- JScreen — Sharsheret's partner for accessible, lab-based at-home genetic screening.
- Face the Risk Together support groups — sarachampielcsw.com
- FORCE (Facing Our Risk of Cancer Empowered) — facingourrisk.org — national organization for hereditary cancer advocacy and peer support
- National Society of Genetic Counselors (NSGC) — nsgc.org — find a certified genetic counselor for hereditary cancer risk
If this conversation resonates, follow, rate, and share the show. Find Sara Champie on IG @SaraChampielcsw and sarachampielcsw.com for free resources and access to 1:1 and group support.
You already speak this language — come walk the genetic line with us.
Sara Champie